Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists

British Journal of Pharmacology

Volumn 167, Issue 4, 2012, Pages 763-774

  Broad, J ^a   Mukherjee, S ^a   Samadi, M ^a,c   Martin, J E ^a   Dukes, G E ^b   Sanger, G J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

GSK962040; human; motilin; neurogastroenterology; stomach

Indexed keywords

ACYLTRANSFERASE; CAMICINAL; HORMONE RECEPTOR; HORMONE RECEPTOR STIMULATING AGENT; MOTILIN; MOTILIN RECEPTOR; MOTILIN RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; CHOLINERGIC ACTIVITY; CHOLINERGIC NERVE CELL; COLON; CONCENTRATION RESPONSE; DUODENUM; ELECTROSTIMULATION; FACILITATION; FEMALE; GASTROINTESTINAL TRACT FUNCTION; HUMAN; HUMAN TISSUE; ILEUM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MIGRATING MYOELECTRIC COMPLEX; MUSCLE TONE; MYENTERIC PLEXUS; NERVE STIMULATION; NEUROMUSCULAR FUNCTION; NITRERGIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; SMALL INTESTINE; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; STOMACH ANTRUM; STOMACH EMPTYING; STOMACH FUNDUS; STOMACH MUSCLE; TISSUE FIXATION;

ADULT; AGED; AGED, 80 AND OVER; ELECTRIC STIMULATION; FEMALE; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINES; MALE; MIDDLE AGED; MOTILIN; PIPERAZINES; PIPERIDINES; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, NEUROPEPTIDE; STOMACH;

EID: 84866972210     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02009.x     Document Type: Review

References (54)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to receptors and channels (GRAC), 5th edn. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. Ang DC, Nicolai H, Vos R, Vanden Berghe P, Sifrim D, Depoortere I, et al,. (2008). Gastric phase 3 is a hunger signal in the interdigestive state in man. Gastroenterology 134: A-314.
3. Auli M, Martinez E, Gallego D, Opazo A, Espín F, Martí-Gallostra M, et al,. (2008). Effects of excitatory and inhibitory neurotransmission on motor patterns of human sigmoid colon in vitro. Br J Pharmacol 155: 1043-1055.
4. Bassotti G, Chiarioni G, Vantini I, Morelli A, Whitehead WE, (1998). Effect of different doses of erythromycin on colonic motility in patients with slow transit constipation. Z Gastroenterol 36: 209-213.
5. Boivin MA, Carey MC, Levy H, (2003). Erythromycin accelerates gastric emptying in a dose-response manner in healthy subjects. Pharmacotherapy 23: 5-8.
6. 4 receptor agonists enhance both cholinergic and nitrergic activity in human isolated colon circular muscle. Neurogastroenterol Motil 18: 853-861.
7. Chieppa DM, Mansi G, Rinaldi R, Serio M, Nacci C, Montagnani M, et al,. (2000). Effects of erythromycin on human colonic circular muscle in idiopathic chronic constipation. Eur J Clin Invest 30: 66-71.
8. Costa A, De Ponti F, Gibelli G, Crema F, (1997). In vivo characterisation of the colonic prokinetic effect of erythromycin in the rabbit. Pharmacology 54: 64-75.
9. Coulie B, Tack J, Peeters T, Janssens J, (1998). Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans. Gut 43: 395-400.
10. Dass NB, Hill J, Muir A, Testa T, Wise A, Sanger GJ, (2003). The rabbit motilin receptor: molecular characterisation and pharmacology. Br J Pharmacol 140: 948-954.
11. Desautels SG, Hutson WR, Christian PE, Moore JG, Datz FL, (1995). Gastric emptying in response to variable oral erythromycin dosing in diabetic gastroparesis. Dig Dis Sci 49: 141-146.
12. Dhir R, Richter JE, (2004). Erythromycin in the short- and long-term control of dyspepsia symptoms in patients with gastroparesis. J Clin Gastroenterol 38: 237-242.
13. DiBaise JK, Quigley EM, (1999). Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one centre's experience. J Clin Gastroenterol 28: 131-134.
14. Dukes GE, Barton M, Dewit O, Stephens K, Vasist L, Young M, et al,. (2010). Safety/tolerability, pharmacokinetics (PK), and effect on gastric emptying (GE) with 14-days repeat oral dosing of the motilin receptor agonist, GSK962040, in healthy male and female volunteers. Neurogastroenterol Motil 22: 14-15.
15. Emmanuel AV, Shand AG, Kamm MA, (2004). Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther 19: 687-694.
16. Feighner SD, Tan CP, McKee KK, Palyha OC, Hreniuk DL, Pong S-S, et al,. (1999). Receptor for motilin identified in the human gastrointestinal system. Science 284: 2184-2188.
17. Furness JB, Clark MJ, Wright T, Bertrand PP, Bornstein JC, Verlinden M, (1999). An action of erythromycin in the intestine that is not mediated via motilin receptors. Clin Exp Pharmacol Physiol 26: 100-104.
18. Gagnon DJ, Devroede G, Belisle S, (1972). Excitatory effects of adrenaline upon isolated preparations of human colon. Gut 13: 654-657.
19. He J, Irwin DM, Chen R, Zhang Y, (2010). Stepwise loss of motilin and its specific receptor genes in rodents. J Mol Endocrinol 44: 37-44.
20. Itoh Z, Aizawa S, Takeuchi S, Couch EF, (1975). Hunger contractions and motilin. In:, Vantrappen G, (ed.). Proc Fifth Int Symp Gastrointestinal Motility. Typoff Press: Herentals, pp. 48-55.
21. Jameson JS, Rogers J, Misiewicz JJ, Raimundo AH, Henry MM, (1992). Oral or intravenous erythromycin has no effect on human distal colonic motility. Aliment Pharmacol Ther 6: 589-595.
22. Jarvie EM, North-Laidler V, Corcoran S, Bassil A, Sanger GJ, (2007). Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro. Br J Pharmacol 150: 455-462.
23. Kitazawa T, Taneike T, Ohga A, (1997). Functional characterization of neural and smooth muscle motilin receptors in the chicken proventriculus and ileum. Regul Pept 71: 87-95.
24. Leclere PG, Lefebvre RA, (2002). Presynaptic modulation of cholinergic neurotransmission in the human proximal stomach. Br J Pharmacol 135: 135-142.
25. Lee H-T, Hennig GW, Fleming NW, Keef KD, Spencer NJ, Ward SM, et al,. (2007). Septal interstitial cells of Cajal conduct pacemaker activity to excite muscle bundles in human jejunum. Gastroenterology 133: 907-917.
26. Lee KY, Chang TM, Chey WY, (1983). Effect of rabbit antimotilin serum on myoelectric activity and plasma motilin concentration in fasting dog. Am J Physiol 245: G547-G553.
27. Leming S, Broad J, Cozens SJ, Otterson M, Winchester W, Lee K, et al,. (2011). GSK962040: a small molecule motilin receptor agonist which increases gastrointestinal motility in conscious dogs. Neurogastroenterol Motil 23: 958-964.
28. Lödtke FE, Möller H, Golenhofen K, (1989). Direct effects of motilin on isolated smooth muscle from various regions of the human stomach. Pflügers Arch 414: 558-563.
29. Maganti K, Onyemere K, Jones MP, (2003). Oral erythromycin and symptomatic relief of gastroparesis: a systematic review. Am J Gastroenterol 98: 258-263.
30. Maggi CA, Patacchini R, Santticioli P, Giuliani S, Turini D, Barbanti G, et al,. (1990). Human isolated ileum: motor responses of the circular muscle to electrical field stimulation and exogenous neuropeptides. Naunyn Schmiedebergs Arch Pharmacol 341: 256-261.
31. Miller P, Roy AS, Pierre S, Dagenais M, Lapointe R, Poitras P, (2000). Motilin receptors in the human antrum. Am J Physiol 278: G18-G23.
32. Nakajima H, Mochiki E, Zietlow A, Ludwig K, Takahashi T, (2010). Mechanism of interdigestive migrating motor complex in conscious dogs. J Gastroenterol 45: 506-514.
33. Ohshiro H, Nonaka M, Ichikawa K, (2008). Molecular identification and characterization of the dog motilin receptor. Regul Pept 146: 80-87.
34. Pimont S, Bruley des Varannes S, Le Neel JC, (2003). Neurochemical coding of myenteric neurones in the human gastric fundus. Neurogastroenterol Motil 15: 655-662.
35. Polak JM, Pearse AGE, Heath CM, (1975). Complete identification of endocrine cells in the gastrointestinal tract using semi-thin sections to identify motilin cells in human and animal intestine. Gut 16: 225-229.
36. Porter AJ, Wattchow DA, Brookes SJH, Costa M, (2002). Cholinergic and nitrergic interneurones in the myenteric plexus of the human colon. Gut 51: 70-75.
37. Richards RD, Davenport K, McCallum RW, (1993). The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 88: 203-207.
38. Sanger GJ, (2008). Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases. Drug Discov Today 13: 234-239.
39. Sanger GJ, Westaway SM, Barnes AA, Macpherson DT, Muir AI, Jarvie EM, et al,. (2009). GSK962040A: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility. Neurogastroenterol Motil 21: 657-666.
40. Sanger GJ, Holbrook JD, Andrews PLR, (2011). The translational value of rodent gastrointestinal functions: a cautionary tale. Trends Pharmacol Sci 32: 402-409.
41. Sarna SK, (1985). Cyclic motor activity; migrating motor complex: 1985. Gastroenterology 89: 894-913.
42. Sharma SS, Bhargava N, Mathur SC, (1995). Effect of oral erythromycin on colonic transit in patients with idiopathic constipation. A pilot study. Dig Dis Sci 40: 2446-2449.
43. Takeshita E, Matsuura B, Dong M, Miller LJ, Matsui H, Onji M, (2006). Molecular characterization and distribution of motilin family receptors in the human gastrointestinal tract. J Gastroenterol 41: 223-230.
44. Ter Beek WP, Möller ESM, van den Berg M, Meijer MJ, Biemond I, Lamers CB, (2008). Motilin receptor expression in smooth muscle, myenteric plexus, and mucosa of human inflamed and noninflamed intestine. Inflamm Bowel Dis 14: 612-619.
45. Thielemans L, Depoortere I, Perret J, Robberecht P, Liu Y, Thijs T, et al,. (2005). Desensitization of the human motilin receptor by motilides. J Pharmacol Exp Ther 313: 1397-1405.
46. Tomita R, Igarashi S, Fijisaki S, Koshinaga T, Tanjoh K, (2007). Regulation of enteric nervous system in the proximal and distal parts of the normal human pyloric sphincter -in vitro study. Hepatogastroenterology 54: 1289-1292.
47. Tonini M, De Giorgio R, De Ponti F, Sternini C, Spelta V, Dionigi P, et al,. (2000). Role of nitric oxide- and vasoactive intestinal polypeptide-containing neurones in human gastric fundus strip relaxations. Br J Pharmacol 129: 12-20.
48. 13]motilin in the isolated rabbit gastric antrum. Eur J Pharmacol 337: 267-274.
49. 2+ signalling induced by motilin and erythromycin in the circular smooth muscle of human colon. Neurogastroenterol Motil 13: 27-35.
50. Vantrappen G, Janssens J, Hellemans J, Ghoos Y, (1977). The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 59: 1158-1166.
51. Venkatasubramani N, Rudolph CD, Sood MR, (2008). Erythromycin lacks colon prokinetic effect in children with functional gastrointestinal disorders: a retrospective study. BMC Gastroenterol 8: 38.
52. Westaway SM, Sanger GJ, (2009). The identification and rationale for drugs which act at the motilin receptor. Prog Med Chem 48: 31-80. Ed, Lawton G & Witty D.
53. Wierup N, Björkqvist M, Weström B, Pierzynowski S, Sundler F, Sjölund K, (2007). Ghrelin and motilin are cosecreted from a prominent endocrine cell population in the small intestine. J Clin Endocrinol Metab 92: 3573-3581.
54. Zhao DM, Xue HH, Chida K, Suda T, Oki Y, Kanai M, et al,. (2000). Effect of erythromycin on ATP-induced intracellular calcium response in A549 cells. Am J Physiol 278: L726-L736.